ArisGlobal Launches New NavaX Agent – MedDRA Coding Powered by Agentic AI
A Breakthrough in AI-Powered Pharmacovigilance, the Agent will transform MedDRA coding with context-aware, autonomous decision-making.
A Breakthrough in AI-Powered Pharmacovigilance, the Agent will transform MedDRA coding with context-aware, autonomous decision-making.
Another top-tier pharmaceutical company has chosen LifeSphere Advanced Signals.
At Breakthrough 2025 ArisGlobal unveiled LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs.
This marks the fifth leading pharma organization to adopt LifeSphere NavaX, reinforcing the industry’s trust in AI-driven innovation for drug safety and regulatory operations.
Boston, Massachusetts, USA ...
Over 50 executive speakers and more than 200 expected attendees will explore "AI In Action," advancing automation, GenAI, large language models, and real-world data across pharmacovigilance and regulatory operations
These practices are essential For societal benefits including enhanced patient safety.
These practices are essential For societal benefits including enhanced patient safety.
11 net new LifeSphere customers, 57 customer go-lives, and expanded adoption of NavaX
The latest release brings AI-powered Narrative Generation, enhanced Business Intelligence, and seamless data integrations, empowering life sciences companies to enhance patient safety, quality, and compliance.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved